ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract PS13-05: A phase 2 study of oral paclitaxel and encequidar (oPac+E) in the treatment of cutnaeous angiosarcoma: The breast angiosarcoma subgroup
Mapping Intimacies
◽
10.1158/1538-7445.sabcs20-ps13-05
◽
2021
◽
Author(s):
Vinod Ravi
◽
Michael Wagner
◽
Tom Wei-Wu Chen
◽
Herbert H Loong
◽
Robert Mennel
◽
...
Keyword(s):
Phase 2
◽
Phase 2 Study
◽
Oral Paclitaxel
Download Full-text
Related Documents
Cited By
References
Ataluren in Patients Aged 2 to < 5 Years with Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD): 28-week Results from a Phase 2 Study
10.1055/s-0039-1698256
◽
2019
◽
Author(s):
Christian Werner
◽
Cuixia Tian
◽
Robert Kong
◽
Edward O’Mara
◽
Traci Schilling
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Nonsense Mutation
◽
Phase 2
◽
Phase 2 Study
Download Full-text
NEAR-INFRARED FLUORESCENCE MOLECULAR ENDOSCOPY SHOWS PROMISING RESULTS IN DETECTING DYSPLASTIC ESOPHAGEAL LESIONS USING TOPICALLY ADMINISTERED BEVACIZUMAB-800CW: THE PRELIMINARY RESULTS OF A PHASE 2 STUDY
10.1055/s-0040-1704289
◽
2020
◽
Author(s):
RY Gabriëls
◽
WTR Hooghiemstra
◽
I Schmidt
◽
JJH van der Laan
◽
G Kats-Ugurlu
◽
...
Keyword(s):
Near Infrared
◽
Phase 2
◽
Near Infrared Fluorescence
◽
Preliminary Results
◽
Phase 2 Study
Download Full-text
Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.2.supp.98
◽
2018
◽
Vol 2
◽
pp. S103-S104
Author(s):
Anthony Guzman
Keyword(s):
Molluscum Contagiosum
◽
Phase 2
◽
Phase 2 Study
Abstract not available. Disclosures: None. Copyright 2018 SKIN
Download Full-text
Efficacy, Health-Related Outcomes, and Safety of Ixekizumamb for up to Five Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.1.supp.11
◽
2017
◽
Vol 1
◽
pp. s12
Author(s):
Andrew Blauvelt
◽
Craig Leonardi
◽
Claus Zachariae
◽
Russel Burge
◽
Terri Ridenour
◽
...
Keyword(s):
Plaque Psoriasis
◽
Phase 2
◽
Chronic Plaque Psoriasis
◽
Open Label
◽
Phase 2 Study
◽
Health Related
Abstract Not Available
Download Full-text
Efficacy of F17464, a New Preferential D3 Antagonist in a Placebo-controlled Phase 2 Study of Patients With an Acute Exacerbation of Schizophrenia
10.26226/morressier.58a41cf4d462b8028d8930e0
◽
2017
◽
Author(s):
Francoise Tonner
Keyword(s):
Acute Exacerbation
◽
Phase 2
◽
Phase 2 Study
Download Full-text
16 / Axicabtagene Ciloleucel in Patients With Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1
10.26226/morressier.5b3b802db1b87b000eceda9c
◽
2018
◽
Author(s):
Locke Frederick L.
Keyword(s):
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Phase 2
◽
Pivotal Phase
◽
Large B Cell Lymphoma
◽
Phase 2 Study
◽
Large B Cell
Download Full-text
A Phase 2 Study of Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma
Case Medical Research
◽
10.31525/ct1-nct03919175
◽
2019
◽
Author(s):
Keyword(s):
Follicular Lymphoma
◽
Marginal Zone
◽
Initial Therapy
◽
Marginal Zone Lymphoma
◽
Phase 2
◽
Phase 2 Study
Download Full-text
A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
Case Medical Research
◽
10.31525/ct1-nct03911713
◽
2019
◽
Author(s):
Keyword(s):
Cystic Fibrosis
◽
Phase 2
◽
Efficacy And Safety
◽
Phase 2 Study
Download Full-text
A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL
Case Medical Research
◽
10.31525/ct1-nct03980002
◽
2019
◽
Author(s):
Keyword(s):
Phase 2
◽
Multicenter Phase
◽
Phase 2 Study
◽
Treatment Naïve
Download Full-text
A Phase 2 Study for Dose Determination of SRP-5051, Then Dose Expansion in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
Case Medical Research
◽
10.31525/ct1-nct04004065
◽
2019
◽
Author(s):
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Phase 2
◽
Dose Determination
◽
Phase 2 Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close